Filed: 8/14/2025ACC: 0001892688-25-000149
📋 What this filing means
DIADEMA PARTNERS LP filed this quarterly 13F‑HR report disclosing 75 equity positions with a total reported market value of $328.22M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
75
Positions
$328.22M
Total AUM (reported)
23.61M
Total Shares
Allocation by class
COM$261.35M79.6%
SHS USD$16.39M5.0%
COM NEW$11.58M3.5%
S&P BIOTECH$8.29M2.5%
ADR$6.92M2.1%
NAMEN AKT$5.45M1.7%
SPON ADS$3.68M1.1%
Portfolio Concentration
Top 3$91.17M27.8%
4–10$85.08M25.9%
11–25$82.21M25.0%
Rest$69.75M21.3%
Top 3 weight
27.8%
Top 10 weight
53.7%
Voting Authority Distribution
Total shares with voting rights: 23.61M
Sole
Full voting authority
23.61M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole75
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings75
Rows:
ELI LILLY & CO
SOLEShares45.52K
TypeSH
Market value$35.48M
10.81%
Sole
45.52K
Shared
0.00
None
0.00
AMGEN INC
SOLEShares114.20K
TypeSH
Market value$31.89M
9.71%
Sole
114.20K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares284.15K
TypeSH
Market value$23.81M
7.25%
Sole
284.15K
Shared
0.00
None
0.00
JAZZ PHARMACEUTICALS PLC
SOLEShares154.47K
TypeSH
Market value$16.39M
4.99%
Sole
154.47K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares394.29K
TypeSH
Market value$14.34M
4.37%
Sole
394.29K
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares371.45K
TypeSH
Market value$13.37M
4.07%
Sole
371.45K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares94.04K
TypeSH
Market value$11.82M
3.60%
Sole
94.04K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares192.88K
TypeSH
Market value$10.60M
3.23%
Sole
192.88K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares279.08K
TypeSH
Market value$10.27M
3.13%
Sole
279.08K
Shared
0.00
None
0.00
SPDR SERIES TRUST
SOLEShares100K
TypeSH
Market value$8.29M
2.53%
Sole
100K
Shared
0.00
None
0.00
CORCEPT THERAPEUTICS INC
SOLEShares100.20K
TypeSH
Market value$7.35M
2.24%
Sole
100.20K
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares166.87K
TypeSH
Market value$7.25M
2.21%
Sole
166.87K
Shared
0.00
None
0.00
NOVO-NORDISK A S
SOLEShares100K
TypeSH
Market value$6.90M
2.10%
Sole
100K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares198.28K
TypeSH
Market value$6.45M
1.96%
Sole
198.28K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares131.40K
TypeSH
Market value$5.67M
1.73%
Sole
131.40K
Shared
0.00
None
0.00
MODERNA INC
SOLEShares202.10K
TypeSH
Market value$5.58M
1.70%
Sole
202.10K
Shared
0.00
None
0.00
ALTIMMUNE INC
SOLEShares1.43M
TypeSH
Market value$5.55M
1.69%
Sole
1.43M
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares112K
TypeSH
Market value$5.45M
1.66%
Sole
112K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares197.47K
TypeSH
Market value$5.23M
1.59%
Sole
197.47K
Shared
0.00
None
0.00
ARS PHARMACEUTICALS INC
SOLEShares280.70K
TypeSH
Market value$4.90M
1.49%
Sole
280.70K
Shared
0.00
None
0.00
PFIZER INC
SOLEShares200K
TypeSH
Market value$4.85M
1.48%
Sole
200K
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
SOLEShares10K
TypeSH
Market value$4.45M
1.36%
Sole
10K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares600.51K
TypeSH
Market value$4.31M
1.31%
Sole
600.51K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares76.19K
TypeSH
Market value$4.21M
1.28%
Sole
76.19K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
SOLEShares122.10K
TypeSH
Market value$4.06M
1.24%
Sole
122.10K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ELI LILLY & COSOLE | COM | 45.52K | SH | $35.48M 10.81% | 45.52K | 0.00 | 0.00 |
AMGEN INCSOLE | COM | 114.20K | SH | $31.89M 9.71% | 114.20K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 284.15K | SH | $23.81M 7.25% | 284.15K | 0.00 | 0.00 |
JAZZ PHARMACEUTICALS PLCSOLE | SHS USD | 154.47K | SH | $16.39M 4.99% | 154.47K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 394.29K | SH | $14.34M 4.37% | 394.29K | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 371.45K | SH | $13.37M 4.07% | 371.45K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 94.04K | SH | $11.82M 3.60% | 94.04K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 192.88K | SH | $10.60M 3.23% | 192.88K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 279.08K | SH | $10.27M 3.13% | 279.08K | 0.00 | 0.00 |
SPDR SERIES TRUSTSOLE | S&P BIOTECH | 100K | SH | $8.29M 2.53% | 100K | 0.00 | 0.00 |
CORCEPT THERAPEUTICS INCSOLE | COM | 100.20K | SH | $7.35M 2.24% | 100.20K | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 166.87K | SH | $7.25M 2.21% | 166.87K | 0.00 | 0.00 |
NOVO-NORDISK A SSOLE | ADR | 100K | SH | $6.90M 2.10% | 100K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 198.28K | SH | $6.45M 1.96% | 198.28K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 131.40K | SH | $5.67M 1.73% | 131.40K | 0.00 | 0.00 |
MODERNA INCSOLE | COM | 202.10K | SH | $5.58M 1.70% | 202.10K | 0.00 | 0.00 |
ALTIMMUNE INCSOLE | COM NEW | 1.43M | SH | $5.55M 1.69% | 1.43M | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 112K | SH | $5.45M 1.66% | 112K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 197.47K | SH | $5.23M 1.59% | 197.47K | 0.00 | 0.00 |
ARS PHARMACEUTICALS INCSOLE | COM | 280.70K | SH | $4.90M 1.49% | 280.70K | 0.00 | 0.00 |
PFIZER INCSOLE | COM | 200K | SH | $4.85M 1.48% | 200K | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCSOLE | COM | 10K | SH | $4.45M 1.36% | 10K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 600.51K | SH | $4.31M 1.31% | 600.51K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 76.19K | SH | $4.21M 1.28% | 76.19K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCSOLE | COM | 122.10K | SH | $4.06M 1.24% | 122.10K | 0.00 | 0.00 |
Page 1 of 3